Ans C.P. Wiesfeld

4.7k total citations
67 papers, 2.5k citations indexed

About

Ans C.P. Wiesfeld is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Orthopedics and Sports Medicine. According to data from OpenAlex, Ans C.P. Wiesfeld has authored 67 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 9 papers in Orthopedics and Sports Medicine. Recurrent topics in Ans C.P. Wiesfeld's work include Cardiac electrophysiology and arrhythmias (37 papers), Cardiac Arrhythmias and Treatments (29 papers) and Cardiovascular Effects of Exercise (19 papers). Ans C.P. Wiesfeld is often cited by papers focused on Cardiac electrophysiology and arrhythmias (37 papers), Cardiac Arrhythmias and Treatments (29 papers) and Cardiovascular Effects of Exercise (19 papers). Ans C.P. Wiesfeld collaborates with scholars based in Netherlands, United States and Germany. Ans C.P. Wiesfeld's co-authors include Arthur A.M. Wilde, J. Peter van Tintelen, Richard N.W. Hauer, Maarten P. van den Berg, Harry J.G.M. Crijns, Dirk J. van Veldhuisen, Irene M. van Langen, Isabelle C. Van Gelder, Robert M.W. Hofstra and Marcel M. A. M. Mannens and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Investigation.

In The Last Decade

Ans C.P. Wiesfeld

66 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ans C.P. Wiesfeld Netherlands 24 2.2k 701 412 103 103 67 2.5k
Anna Iglesias Spain 27 1.6k 0.7× 863 1.2× 81 0.2× 93 0.9× 163 1.6× 74 2.0k
Georgia Sarquella‐Brugada Spain 25 1.8k 0.8× 792 1.1× 106 0.3× 228 2.2× 105 1.0× 117 2.1k
Avi Fischer United States 20 1.2k 0.6× 385 0.5× 16 0.0× 274 2.7× 57 0.6× 47 1.7k
Leigh D. Segel United States 14 192 0.1× 101 0.1× 46 0.1× 77 0.7× 33 0.3× 30 572
M Matsuda Japan 11 709 0.3× 91 0.1× 31 0.1× 178 1.7× 12 0.1× 29 940
Carl Timmermans Netherlands 29 2.6k 1.2× 156 0.2× 15 0.0× 193 1.9× 33 0.3× 98 2.8k
Andrea Sarkozy Belgium 31 2.7k 1.2× 854 1.2× 5 0.0× 184 1.8× 94 0.9× 162 2.9k
Amanda J. Cox United States 16 271 0.1× 96 0.1× 27 0.1× 106 1.0× 17 0.2× 33 713
Yuta Kagaya Japan 11 113 0.1× 72 0.1× 65 0.2× 69 0.7× 20 0.2× 14 468
Noriko Nara Japan 14 102 0.0× 150 0.2× 27 0.1× 120 1.2× 18 0.2× 27 732

Countries citing papers authored by Ans C.P. Wiesfeld

Since Specialization
Citations

This map shows the geographic impact of Ans C.P. Wiesfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ans C.P. Wiesfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ans C.P. Wiesfeld more than expected).

Fields of papers citing papers by Ans C.P. Wiesfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ans C.P. Wiesfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ans C.P. Wiesfeld. The network helps show where Ans C.P. Wiesfeld may publish in the future.

Co-authorship network of co-authors of Ans C.P. Wiesfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Ans C.P. Wiesfeld. A scholar is included among the top collaborators of Ans C.P. Wiesfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ans C.P. Wiesfeld. Ans C.P. Wiesfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gelder, Isabelle C. Van, Hessel F. Groenveld, Robert G Tieleman, et al.. (2022). Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study. BMJ Open. 12(11). e063359–e063359. 1 indexed citations
2.
Mulder, Bart A., Hessel F. Groenveld, Ans C.P. Wiesfeld, et al.. (2022). Initial experience with pulsed field ablation for atrial fibrillation. Frontiers in Cardiovascular Medicine. 9. 959186–959186. 24 indexed citations
3.
Mulder, Bart A., Hessel F. Groenveld, Robert G Tieleman, et al.. (2021). Identifying patients with atrial fibrillation recurrences after two pulmonary vein isolation procedures. Open Heart. 8(2). e001718–e001718. 2 indexed citations
4.
Mulder, Bart A., Eng S. Tan, Ans C.P. Wiesfeld, et al.. (2019). Pulmonary vein anatomy addressed by computed tomography and relation to success of second‐generation cryoballoon ablation in paroxysmal atrial fibrillation. Clinical Cardiology. 42(4). 438–443. 14 indexed citations
5.
Groeneweg, Judith A., Paul A. van der Zwaag, Louise R.A. Olde Nordkamp, et al.. (2013). Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Revised 2010 Task Force Criteria With Inclusion of Non-Desmosomal Phospholamban Mutation Carriers. The American Journal of Cardiology. 112(8). 1197–1206. 39 indexed citations
6.
Smit, Marcelle D., Alexander H. Maass, Hans L. Hillege, et al.. (2011). Prognostic Importance of Natriuretic Peptides and Atrial Fibrillation in Patients Receiving Cardiac Resynchronization Therapy. European Journal of Heart Failure. 13(5). 543–550. 23 indexed citations
7.
Groeneweg, Judith A., Paul A. van der Zwaag, Christian van der Werf, et al.. (2011). Abstract 12326: Revised 2010 Task Force Criteria for ARVD/C Diagnosis Promote Inclusion of Non-Desmosomal Mutation Carriers. Circulation. 124. 1 indexed citations
8.
Zwaag, Paul A. van der, Maarten P. van den Berg, Moniek G.P.J. Cox, et al.. (2010). One Mutation Fits All: Phospholamban R14del Causes Both Dilated Cardiomyopathy and Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Circulation. 122(21). 3 indexed citations
9.
Cox, Moniek G.P.J., Jasper J. van der Smagt, Maartje Noorman, et al.. (2010). Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Diagnostic Task Force Criteria. Circulation Arrhythmia and Electrophysiology. 3(2). 126–133. 56 indexed citations
10.
Tintelen, J. Peter van, Isabelle C Van Gelder, Angeliki Asimaki, et al.. (2009). Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. Heart Rhythm. 6(11). 1574–1583. 117 indexed citations
11.
Rienstra, Michiel, Harry J.G.M. Crijns, Thera P. Links, et al.. (2008). Continuous vs Episodic Prophylactic Treatment With Amiodarone for the Prevention of Atrial Fibrillation. JAMA. 300(15). 1784–1784. 45 indexed citations
12.
Cox, Moniek G.P.J., Marcel Nelen, Arthur A.M. Wilde, et al.. (2008). Activation Delay and VT Parameters in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Toward Improvement of Diagnostic ECG Criteria. Journal of Cardiovascular Electrophysiology. 19(8). 775–781. 76 indexed citations
13.
Smagt, Jasper J. van der, Moniek G.P.J. Cox, Marcel Nelen, et al.. (2007). Abstract 2723: Large Genomic Deletions in Plakophilin-2 are a Rare Cause of ARVD/C and ARVD/C-like Disease.. Circulation. 116(suppl_16). 1 indexed citations
14.
Crijns, Harry J.G.M., Dirk J. van Veldhuisen, Nic J.G.M. Veeger, et al.. (2006). Verapamil Versus Digoxin and Acute Versus Routine Serial Cardioversion for the Improvement of Rhythm Control for Persistent Atrial Fibrillation. Journal of the American College of Cardiology. 48(5). 1001–1009. 23 indexed citations
15.
Gu, Youlan L., Anton E. Tuinenburg, Piet W. Boonstra, et al.. (2006). Favorable Long-Term Outcome of Maze Surgery in Patients With Lone Atrial Fibrillation. The Annals of Thoracic Surgery. 81(5). 1773–1779. 27 indexed citations
16.
Tuininga, Ype S., et al.. (1996). Electrophysiological, Rate Dependent, and Autonomic Effects of the Class III Antiarrhythmic Almokalant After Myocardial Infarction in the Pig. Pacing and Clinical Electrophysiology. 19(5). 802–810. 1 indexed citations
17.
Wiesfeld, Ans C.P., Harry J.G.M. Crijns, Hans L. Hillege, Ype S. Tuininga, & K.I. Lie. (1995). The clinical significance of coronary anatomy in post-infarct patients with late sustained ventricular tachycardia or ventricular fibrillation. European Heart Journal. 16(6). 818–824. 9 indexed citations
18.
Tuininga, Ype S., Harry J.G.M Crijns, Ans C.P. Wiesfeld, et al.. (1993). Electrocardiographic patterns relative to initiating mechanisms of exercise-induced ventricular tachycardia. American Heart Journal. 126(2). 359–367. 10 indexed citations
19.
Tuininga, Ype S., et al.. (1991). Value of target-directed endomyocardial biopsy in idiopathic right ventricular tachycardia. Journal of the American College of Cardiology. 17(2). A97–A97. 4 indexed citations
20.
Remme, Willem J., et al.. (1989). Hemodynamic Effects of Intravenous Pimobendan in Patients with Left Ventricular Dysfunction. Journal of Cardiovascular Pharmacology. 14. S45–S45. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026